RENEURON LIMITED
RENEURON LIMITED is a Private limited company (Ltd.) registered in United Kingdom under 03375897, and its current status with Companies House is active. The company was incorporated on 23 May 1997 and lists its registered address as Weybridge, United Kingdom. 2 shareholders are on record for RENEURON LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 25 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Shareholders of RENEURON LIMITED
Two shareholders are currently on record for RENEURON LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is RENEURON GROUP PLC, holding 99.8% — a majority holding — followed by RENEURON GROUP PLC at 0.2%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| RENEURON GROUP PLC | 99.8% | Companies House | |
| RENEURON GROUP PLC | 0.2% | Companies House |
Officers
28
Directors and officers of RENEURON LIMITED
Three of the 28 officer records shown for RENEURON LIMITED are current appointments, filed with Companies House. Iain Ross (appointed 2022-12-31) and Randolph Corteling (appointed 2025-03-21) both serve as Director; Keith Parrish (appointed 2025-03-27) serves as Company Secretary. The remaining 25 records shown (Instant Companies Limited, Elizabeth Holt and 22 others) are former appointments that have since been resigned. Management authority at RENEURON LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of RENEURON LIMITED
RENEURON LIMITED sits 1 level below its ultimate parent, RENEURON GROUP LIMITED, registered in United Kingdom. The full chain up to RENEURON GROUP LIMITED is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by RENEURON LIMITED's own shareholder record.
RENEURON GROUP LIMITED
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns RENEURON LIMITED?
Two shareholders are currently on record for RENEURON LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is RENEURON GROUP PLC, holding 99.8% — a majority holding — followed by RENEURON GROUP PLC at 0.2%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is RENEURON LIMITED's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for RENEURON LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does RENEURON LIMITED have on record?
2 shareholders are shown on record for RENEURON LIMITED.
What is RENEURON LIMITED's company registration number?
RENEURON LIMITED's registration number is 03375897, filed with Companies House in United Kingdom. Its current status on the register is active.
Is RENEURON LIMITED still an active company?
RENEURON LIMITED's status on Companies House is listed as active.
When was RENEURON LIMITED incorporated?
RENEURON LIMITED was incorporated on 23 May 1997, according to Companies House.
What is RENEURON LIMITED's registered address?
The registered address on file for RENEURON LIMITED is Weybridge, United Kingdom.
What legal structure is RENEURON LIMITED registered as?
RENEURON LIMITED is registered as a Private limited company (Ltd.) in United Kingdom.
Who are the officers/directors of RENEURON LIMITED?
Three of the 28 officer records shown for RENEURON LIMITED are current appointments, filed with Companies House. Iain Ross (appointed 2022-12-31) and Randolph Corteling (appointed 2025-03-21) both serve as Director; Keith Parrish (appointed 2025-03-27) serves as Company Secretary. The remaining 25 records shown (Instant Companies Limited, Elizabeth Holt and 22 others) are former appointments that have since been resigned. Management authority at RENEURON LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does RENEURON LIMITED have a parent company or subsidiaries?
RENEURON LIMITED sits 1 level below its ultimate parent, RENEURON GROUP LIMITED, registered in United Kingdom.
Can Zavia monitor changes to RENEURON LIMITED's ownership over time?
This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to RENEURON LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access RENEURON LIMITED's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like RENEURON LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies House and was last synced on 25 September 2026.